AI diagnostics company IDx has signed an exclusivity agreement with ophthalmic device maker Topcon to scale AI - based diagnostic ##s in the US . The deal makes IDx the only autonomous AI firm able to sell products with the Topcon NW400 robotic camera , which detects diabetic retinopathy in its images . IDx ’s AI system , IDx - DR , was approved by the US Food and Drug Administration earlier this year after a clinical trial . diagnosed with diabetes who have not been previously diagnosed with diabetic retinopathy. Operators with minimal training produced a result 96 % of the time , capturing images with the Topcon NW400 , which the IDx - DR system needed to make a disease assessment .
AI diagnostics company IDx has signed an exclusivity agreement with ophthalmic device maker Topcon to scale AI - based diagnostic ##s in the US . The deal makes IDx the only autonomous AI firm able to sell products with the Topcon NW400 robotic camera , which detects diabetic retinopathy in its images . IDx ’s AI system , IDx - DR , was approved by the US Food and Drug Administration earlier this year after a clinical trial . Operators with minimal training produced a result 96 % of the time , capturing images with the Topcon NW400 , which the IDx - DR system needed to make a disease assessment .